- Home
- HTBK vs IMTX Comparison
HTBK vs IMTX Comparison
Compare HTBK & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTBK
- IMTX
- Stock Information
- Founded
- HTBK 1997
- IMTX N/A
- Country
- HTBK United States
- IMTX Germany
- Employees
- HTBK N/A
- IMTX N/A
- Industry
- HTBK Major Banks
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTBK Finance
- IMTX Health Care
- Exchange
- HTBK Nasdaq
- IMTX Nasdaq
- Market Cap
- HTBK 557.0M
- IMTX 579.8M
- IPO Year
- HTBK 1998
- IMTX N/A
- Fundamental
- Price
- HTBK $9.26
- IMTX $5.39
- Analyst Decision
- HTBK Buy
- IMTX Strong Buy
- Analyst Count
- HTBK 3
- IMTX 4
- Target Price
- HTBK $11.33
- IMTX $14.67
- AVG Volume (30 Days)
- HTBK 272.7K
- IMTX 626.4K
- Earning Date
- HTBK 07-24-2025
- IMTX 05-13-2025
- Dividend Yield
- HTBK 5.62%
- IMTX N/A
- EPS Growth
- HTBK N/A
- IMTX N/A
- EPS
- HTBK 0.68
- IMTX N/A
- Revenue
- HTBK $174,083,000.00
- IMTX $155,801,989.00
- Revenue This Year
- HTBK $8.90
- IMTX N/A
- Revenue Next Year
- HTBK $5.91
- IMTX $5.38
- P/E Ratio
- HTBK $13.62
- IMTX N/A
- Revenue Growth
- HTBK N/A
- IMTX 93.56
- 52 Week Low
- HTBK $7.74
- IMTX $3.30
- 52 Week High
- HTBK $11.27
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- HTBK 51.52
- IMTX 60.57
- Support Level
- HTBK $8.92
- IMTX $4.93
- Resistance Level
- HTBK $9.30
- IMTX $5.31
- Average True Range (ATR)
- HTBK 0.16
- IMTX 0.37
- MACD
- HTBK -0.01
- IMTX 0.05
- Stochastic Oscillator
- HTBK 45.95
- IMTX 84.93
About HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.